Tens of thousands of lives could be saved by pioneering research to detect deadly diseases before symptoms even appear, thanks to a new collaboration between the government and the Life Sciences Industry.
The Taskforce for Lung Health – which the ABPI is a member - is today calling for an inexpensive breath test to be much more widely used in GP practices, community health services and hospitals to improve the diagnosis of lung disease.
The European Council has endorsed the Agreement on the withdrawal of the UK from the EU and has approved the Political Declaration setting out the framework for the future relationship between the UK and the EU.
A coalition from the UK’s health sector say Brexit negotiators have a responsibility to protect 500 million patients on both sides of the Channel. The group is calling on both sides to make patients and public health central to the Political Declaration for the future relationship between the UK...
UK Marketing Authorisation Holders urged to register with SecurMed UK
Responding to the announcement of the Withdrawal Agreement and political declaration on the UK’s future relationship with the EU, the Association of the British Pharmaceutical Industry welcomes an important step towards securing a Brexit deal.
The Association of the British Pharmaceutical Industry (ABPI) has welcomed NHS England’s new publication summarising the recent regional workshops held on biosimilar medicines.
NHS England, the Association of the British Pharmaceutical Industry (ABPI) and the AHSN Network have joined forces to launch an ambitious new programme, connecting digital health innovators with pharmaceutical companies to explore new innovations that could help people living with diabetes.
The Court has today made a judgment on the use of Avastin to treat a condition called wet age-related macular degeneration (wet AMD).
The Association of the British Pharmaceutical Industry (ABPI) and the AHSN Network today announce a new, five-year partnership to accelerate the introduction and uptake of transformative biomedical innovations into the NHS.